Skip to main content
S 303 108th Congress Senate Health Cloning Congress Congressional oversight Congressional reporting requirements Crime and Law Enforcement Cytology Donation of organs, tissues, etc. Ethics Federal-state relations Fines (Penalties) Forfeiture Genetics Government Operations and Politics Human embryology In vitro fertilization International Affairs Laboratories Law Medical research

Human Cloning Ban and Stem Cell Research Protection Act of 2003

Introduced: February 5, 2003 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2003
Read twice and referred to the Committee on the Judiciary.
Feb 5, 2003
Introduced in Senate
 Plain-English summary Congressional Research Service
Human Cloning Ban and Stem Cell Research Protection Act of 2003 - Amends the Federal criminal code to prohibit: (1) conducting or attempting to conduct human cloning; (2) shipping the product of nuclear transplantation for the purpose of human cloning in the United States or elsewhere; or (3) exporting to a foreign country an unfertilized blastocyst if such country does not prohibit human cloning.

Requires the Comptroller General to report to the congressional judiciary committees on: (1) actions taken to enforce such prohibitions; (2) actions of State attorneys general to enforce similar State laws; (3) the Federal-State-local government coordination of enforcement actions; and (4) international laws relating to human cloning.

Amends the Public Health Service Act to require research involving nuclear transplantation to be conducted in accordance with applicable Federal standards for the protection of human subjects. Prohibits: (1) a somatic cell nucleus from being transplanted into a human oocyte (egg) that has undergone or will undergo fertilization; (2) an unfertilized blastocyst from being maintained after more than 14 days from its first cell division, not counting storage times at temperatures less than zero degrees centigrade; (3) an oocyte from being used in nuclear transplantation research unless donated voluntarily with the donor's informed consent; (4) an oocyte or unfertilized blastocyst from being acquired, received, or transferred for valuable consideration in interstate commerce; or (5) the conduct in a laboratory of nuclear transplantation in which human oocytes are subject to assisted reproductive technology treatments or procedures.

What's happening now February 5, 2003

Read twice and referred to the Committee on the Judiciary.

 Committees of jurisdiction 1